[The engineered thymidylate kinase (TMPK)/azidothymidine (AZT)-axis offers efficient bystander cell killing effect for suicide gene therapy for cancer].
Takeya
T
Sato
Teruyuki
T
Yanagisawa
D000818:Animals; D017209:Apoptosis; D024201:Bystander Effect; D015316:Genetic Therapy; D006801:Humans; D009369:Neoplasms / Q000201:enzymology / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D009703:Nucleoside-Phosphate Kinase / Q000378:metabolism*; D015215:Zidovudine / Q000627:therapeutic use*
D015215:Zidovudine; D009703:Nucleoside-Phosphate Kinase; C020093:dTMP kinase